Zpět na seznam článků
31.10.2010
Klener Pavel
Prof. MUDr., DrSc.
Born April 9, 1937, † September 20, 2024
- Internal medicine, clinical oncology and haematology
- Member of Learned Society since 1997
Educational and professional preparation
- 1961, graduate, Faculty of General Medicine, Charles University
- 1961-1988, secondary physician, professional assistant, Associate Professor and Full Professor, Second Clinic of Internal Medicine
- 1988-1990, Head, Clinic of Oncology
- 1990-2008, Head, First Clinic of Internal Medicine
- Qualification certification in internal medicine Level I (1964); Level II (1967), in haematology (1971), in oncology (1982) and in organization and management (1987)
- Defended CSc. thesis in 1976 and doctoral thesis in 1986
- Appointed Associate Professor in 1982 and Full Professor in 1988
Employment and academic positions
- First Clinic of Internal Medicine, CU, and Institute of Haematology and Blood Transfusion, Head, Clinic, Director of IHBT (2002-2007)
- 1990-1993, Vice-Dean for science
- 1994-2006, Vice-Rector for science
- 1989-1990, the first post November Minister of Health of CR
- 1990-1992, Member of Parliament, Czech National Council for Civic Forum
- 1992-1998, Member of Government Council for Science and Research
Membership and positions in international organizations and societies
- American Society for Clinical Oncology
- European Association for Cancer Research
- International Society of Haematology
- Multinational Association for Supportive Care in Cancer
Notable awards
- 1997, Prize, Minister of Education, Youth and Sports (for science)
- 1997, Gold Medal, Charles University
- 1998, Stašek Award, Paul Janssen Foundation
- 2003, Prize, Czech Literary Fund (for scientific literature), Hlávka Foundation
- 2003, Award for merit in area of science, President of Czech Republic
- 2007, Award of the Academy of Science „De scientia et humanitate optime meritis“
- 2010, Award of Primator of Prague (for scientific congresses organized in Prage)
Selected publications
- Vinca alkaloids. Experimental and clinical trials. Carolinum, Prague 1974, 161 pp.
- Anti-tumour chemotherapy. Galén, Prague 1996, 614 pp.
- Cytokines in internal medicine. Grada, Prague 1997, 260 pp.
- Internal medicine. Galen-Karolinum, Prague 1999, 2001, 2006, 2011, 949 pp.
- Clinical oncology. Galen-Karolinum, Prague 1999, 2002, 685 pp.
- New anticancer drugs and treatment strategies in oncology, Grada Publish 2010
Připomeňte si diskuse Učené společnosti o open access, o predátorských vydavatelstvích a o dalších aspektech vědeckého publikování:
11.ledna 2023, moderoval Jan Trlifaj:
Open access – pozitiva a rizika
- prof. Michal Hocek (Učená společnost ČR a ÚOCHB AV ČR)
- Ing. Jiří Marek (ÚVT Masarykovy univerzity)
- doc. Daniel Münich (CERGE-EI)
- doc. David Kosař (Právnická fakulta Masarykovy univerzity)
- Ing. Martin Svoboda (NTK a CzechELib)
- dr. Václav Štětka (Loughborough University, UK)
- prof. Jan Trka (2. LF Univerzity Karlovy)
17. ledna 2023, moderoval Martin Loebl:
Heroic Librarians Fighting Publishing Sharks
- Vinciane Gaillard (Zástupce ředitele European University Association)
- Jiří Jirát (člen vyjednávacího týmu CzechELib)
- Gerard Meijer (ředitel Ústavu Fritze Habera MPG a místopředseda německého vyjednávacího týmu DEAL)
- Martin Svoboda (ředitel NTK, vedoucí vyjednávacího týmu pro elektronické zdroje)